Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New directions in antimicrobial therapy.

J N Greene1, S J Poblete, D Krieff

  • 1Division of Infectious and Tropical Diseases, University of South Florida College of Medicine, Tampa, USA.

Chest Surgery Clinics of North America
|March 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Refractory Pulmonary Coccidioidomycosis Successfully Treated with Posaconazole Therapy.

Journal of family medicine·2018
Same author

Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.

The Journal of hospital infection·2017
Same author

Facial cellulitis by Pseudomonas aeruginosa in a neutropenic patient.

Cancer control : journal of the Moffitt Cancer Center·2001
Same author

Infectious complications of cutaneous t-cell lymphoma.

Cancer control : journal of the Moffitt Cancer Center·2001
Same author

Pathologic manifestations of invasive pulmonary aspergillosis in cancer patients: the many faces of aspergillus.

Cancer control : journal of the Moffitt Cancer Center·2000
Same author

Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.

Cancer control : journal of the Moffitt Cancer Center·2000
Same journal

New treatment modalities for end-stage emphysema.

Chest surgery clinics of North America·2003
Same journal

Cost effectiveness of lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Results of lung volume reduction surgery for emphysema.

Chest surgery clinics of North America·2003
Same journal

Complications after lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Operative techniques for lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Patient selection for lung volume reduction surgery.

Chest surgery clinics of North America·2003
See all related articles

New antimicrobial therapies combat drug-resistant pathogens, offering hope against infections. This study reviews current treatments and their impact on mortality and healthcare costs.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Virulent microorganisms rapidly develop resistance to antimicrobial agents.
  • Multidrug resistance is a growing global health concern.
  • Simultaneous resistance to all antibiotics is rare but poses significant challenges.

Purpose of the Study:

  • To review current antimicrobial agents used for treating resistant pathogens.
  • To evaluate monotherapy and combination strategies.
  • To analyze the impact of these infections on mortality and healthcare costs.

Main Methods:

  • Literature review of current antimicrobial treatments.
  • Analysis of treatment outcomes for resistant pathogens.
  • Review of mortality rates and economic burden associated with resistant infections.

Related Experiment Videos

Main Results:

  • Several current antimicrobials demonstrate efficacy in monotherapy or combination treatments.
  • Successful treatment of highly resistant pathogens is achievable with specific agents.
  • Infections caused by resistant microorganisms are associated with increased mortality and substantial treatment costs.

Conclusions:

  • Effective antimicrobial strategies are crucial for managing drug-resistant infections.
  • Combination therapies may offer advantages in treating complex cases.
  • Addressing antimicrobial resistance requires ongoing research and economic evaluation.